Triple therapy in type 2 diabetes: insulin glargine or rosiglitazone added to combination therapy of sulfonylurea plus metformin in insulin-naive patients.

Source:http://linkedlifedata.com/resource/pubmed/id/16505505

Download in:

View as

General Info

PMID
16505505